Nestor; John J

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nestor; John J.The latest application filed is for "glp-1r and gcgr agonists, formulations, and methods of use".

Company Profile

0.24.17

Nestor; John J - Sugar Land TX
Nestor; John J. - Encinitas CA
NESTOR; John J. - Sugar Land TX
Nestor, John J. - Laguna Niguel CA
Nestor, John J. - Bedford MA
Nestor; John J. - Cupertino CA
Nestor; John J. - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GLP-1R and GCGR Agonists, Formulations, and Methods of Use App 20210290732 - Nestor; John J ; et al.	2021-09-23
Peptide pharmaceuticals for insulin resistance Grant 11,065,304 - Nestor July 20, 2	2021-07-20
Improved Peptide Pharmaceuticals App 20210077629 - NESTOR; John J.	2021-03-18
Improved Peptide Pharmaceuticals For Treatment Of Nash And Other Disorders App 20200352900 - Nestor; John J	2020-11-12
Improved Peptide Pharmaceuticals For Insulin Resistance App 20200289653 - Nestor; John J.	2020-09-17
Peptide Pharmaceuticals For Insulin Resistance App 20200277351 - NESTOR; John J.	2020-09-03
Peptide pharmaceuticals for insulin resistance Grant 10,577,405 - Nestor	2020-03-03
Peptide pharmaceuticals for insulin resistance Grant 10,471,127 - Nestor Nov	2019-11-12
Peptide pharmaceuticals Grant 10,420,844 - Nestor Sept	2019-09-24
Peptide Pharmaceuticals App 20180327454 - Nestor; John J.	2018-11-15
Peptide Pharmaceuticals App 20180296681 - NESTOR; John J.	2018-10-18
Peptide Pharmaceuticals For Insulin Resistance App 20180194826 - NESTOR; John J.	2018-07-12
Peptide pharmaceuticals Grant 10,010,617 - Nestor July 3, 2	2018-07-03
Peptide pharmaceuticals Grant 10,005,817 - Nestor June 26, 2	2018-06-26
Peptide pharmaceuticals for insulin resistance Grant 9,856,306 - Nestor January 2, 2	2018-01-02
Improved Peptide Pharmaceuticals For Insulin Resistance App 20170096468 - NESTOR; John J.	2017-04-06
Improved Peptide Pharmaceuticals App 20150307550 - NESTOR; John J.	2015-10-29
Peptide Pharmaceuticals For Insulin Resistance App 20150290334 - Nestor; John J.	2015-10-15
Peptide Pharmaceuticals App 20150031630 - Nestor; John J.	2015-01-29
Peptide Pharmaceuticals For Insulin Resistance App 20140349928 - Nestor; John J.	2014-11-27
Compounds And Methods Of Treating Metabolic Syndrome And Inflammation App 20080139455 - Nestor; John J.	2008-06-12
Sheet, page, line, position marker App 20040099204 - Nestor, John J.	2004-05-27
Methods for identifying ligands of G-Protein-Coupled receptors App 20020192711 - Nestor, John J. ; et al.	2002-12-19
Synthesis and use for the treatment of osteoporosis Grant 5,874,086 - Krstenansky , et al. February 23, 1	1999-02-23
Analogs of parathyroid hormone and parathyroid hormone relate peptide synthesis and use for the treatment of osteoporosis Grant 5,840,837 - Krstenansky , et al. November 24, 1	1998-11-24
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis Grant 5,807,823 - Krstenansky , et al. September 15, 1	1998-09-15
Process for recombinant production of PTH and PTHrp analogs Grant 5,798,225 - Krstenansky , et al. August 25, 1	1998-08-25
Achiral amino acid acyl esters of ganciclovir and its derivatives Grant 5,543,414 - Nestor , et al. August 6, 1	1996-08-06
.omega.-Guanidino-substituted-.alpha.-amino acids Grant 4,698,442 - Nestor , et al. October 6, 1	1987-10-06
N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides Grant 4,659,693 - Nestor April 21, 1	1987-04-21
Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists Grant 4,581,169 - Nestor , et al. * April 8, 1	1986-04-08
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist Grant 4,530,920 - Nestor , et al. July 23, 1	1985-07-23
Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists Grant 4,481,190 - Nestor , et al. November 6, 1	1984-11-06
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists Grant 4,419,347 - Nestor , et al. * December 6, 1	1983-12-06
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists Grant 4,341,767 - Nestor , et al. * July 27, 1	1982-07-27
Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues Grant 4,318,905 - Nestor , et al. March 9, 1	1982-03-09
Long acting depot injectable formulations for LH-RH analogues Grant 4,256,737 - Nestor , et al. March 17, 1	1981-03-17
Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone Grant 4,234,571 - Nestor , et al. November 18, 1	1980-11-18

Company Registrations

SEC

0001241035

NESTOR JOHN J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.